Human Genetics of Cardiomyopathies

Area of Science:

• Cardiovascular Genetics
• Medical Diagnostics
• Clinical Cardiology

Background:

• Cardiomyopathy diagnosis in a patient can identify disease-causing variants.
• This genetic information facilitates presymptomatic testing in at-risk family members.
• Early identification of carriers is crucial for timely intervention.

Purpose of the Study:

• To highlight the importance of genetic variant identification in cardiomyopathy.
• To emphasize the role of presymptomatic genetic testing in at-risk relatives.
• To underscore the clinical implications of genetic findings for patient management and family screening.

Main Methods:

• Genetic variant identification in diagnosed cardiomyopathy patients.
• Application of findings for presymptomatic genetic testing in relatives.
• Cardiovascular screening protocols for identified carriers.

Main Results:

• Identification of disease-causing variants enables cascade genetic testing.
• Presymptomatic testing allows for early detection of carriers.
• Regular cardiologist screening of carriers can mitigate risks of arrhythmias.

Conclusions:

• Genetic variant identification is pivotal for proactive cardiomyopathy management.
• Presymptomatic testing and regular screening significantly improve outcomes for at-risk families.
• Emerging gene-specific recommendations aid in risk stratification and targeted therapy.